Cell Cycle Regulatory Kinase Modulators: Interim Progress and Issues
Journal:
Current Topics in Medicinal Chemistry
Volume:
5
Page:
1109-1117
Author(s):
Edward A. Sausville
Combining Cytotoxic and Immune-Mediated Gene Therapy to Treat Brain Tumors
Journal:
Current Topics in Medicinal Chemistry
Volume:
5
Page:
1151-1170
Author(s):
James F. Curtin, Gwendalyn D. King, Marianela Candolfi, Remy B. Greeno, Kurt M. Kroeger, Pedro R. Lowenstein and Maria G. Castro
Purine Derivatives as Ligands for A3 Adenosine Receptors
Journal:
Current Topics in Medicinal Chemistry
Volume:
5
Page:
1275-1295
Author(s):
Bhalchandra V. Joshi and Kenneth A. Jacobson
Editorial [Hot Topic: The Endothelin System: Vascular Targets for Therapy in Disease (Guest Editor: Michael R. Dashwood)]
Journal:
Current Vascular Pharmacology
Volume:
3
Page:
305-307
Author(s):
Michael R. Dashwood
Endothelin-1 and Angiogenesis in Cancer
Journal:
Current Vascular Pharmacology
Volume:
3
Page:
309-314
Author(s):
Jonathan Knowles, Marilena Loizidou and Irving Taylor
The Pathobiology of Endothelin-1 in Vein Graft Disease: Are ETA Receptor Antagonists the Solution to Prevent Vein Graft Failure?
Journal:
Current Vascular Pharmacology
Volume:
3
Page:
315-323
Author(s):
Jamie Y. Jeremy, Nilima Shukla, Song Wan, Gavin Murphy, Gianni D. Angelini, Anthony Yim and Michael R. Dashwood
A Role for Endothelin-1 in Peripheral Vascular Disease
Journal:
Current Vascular Pharmacology
Volume:
3
Page:
325-332
Author(s):
Janice C.S. Tsui and Michael R. Dashwood
Endothelin and the Ischaemic Heart
Journal:
Current Vascular Pharmacology
Volume:
3
Page:
333-341
Author(s):
Cherry L. Wainwright, Christopher McCabe and Kathleen A. Kane
Endothelin Signalling in the Cardiac Myocyte and its Pathophysiological Relevance
Journal:
Current Vascular Pharmacology
Volume:
3
Page:
343-351
Author(s):
Peter H. Sugden and Angela Clerk
Endothelin-1 and the Aortic Valve
Journal:
Current Vascular Pharmacology
Volume:
3
Page:
353-357
Author(s):
Adrian H. Chester